The cobas Mass Spec solution Ionify reagent portfolio now covers therapeutic drug monitoring for immunosuppressants and antibiotics
Dr Reddy’s will pay Immutep US$ 20 million upfront and could deliver as much as US$ 349.5 million in regulatory and commercial milestones
Acetaminophen Injection is indicated for the management of mild to moderate pain in adult and pediatric patients 2 years and older
Implementing PFAS testing in the early development stages allows medical device manufacturers to prepare for potential regulatory updates
Sun Pharma to set up Rs. 3,000 crore greenfield formulations facility in MP
The PCR-based test, delivered via Roche’s cobas liat system, allows results to be obtained during a patient consultation in GP practices and Emergency Rooms
The company also revealed that MK-2214 has received Fast Track Designation from the U.S. Food and Drug Administration
In 2024, 59 countries reported large or disruptive measles outbreaks – nearly triple the number reported in 2021 and the highest since the onset of the COVID-19 pandemic
Nitrosamines have prompted evolving global guidelines that demand rigorous industry oversight
AVT03 is a biosimilar of Amgen's Prolia (denosumab 60 mg/mL) and Xgeva (denosumab 70 mg/mL), which are used to treat various bone conditions
Subscribe To Our Newsletter & Stay Updated
